Stefan Braune
4PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 02, 2025
Persistence to Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis: Results from the German NeuroTransData Registry.Stefan Braune, Petra Dirks, Seya Colloud
|Sep 18, 2024
Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments.Erwan Muros-Le Rouzic, Yanic Heer, Sean Yiu
|Aug 02, 2023
The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry.Paul Dillon, Yanic Heer, Eleni Karamasioti
|Aug 12, 2022
How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?Stefan Braune, Arnfin Bergmann, Vladimir Bezlyak
Pageof 1
